Your browser doesn't support javascript.
loading
A real-world cohort analysis of alemtuzumab outcomes in relapsing multiple sclerosis.
Herman, Jorge Acevedo; Khalighinejad, Farnaz; York, Katherine; Radu, Irina; Berrios Morales, Idanis; Ionete, Carolina; Hemond, Christopher C.
Afiliação
  • Herman JA; University of Massachusetts Medical School, Department of Neurology, 55 Lake Avenue North, Worcester, MA, 01655, USA.
  • Khalighinejad F; University of Massachusetts Medical School, Department of Neurology, 55 Lake Avenue North, Worcester, MA, 01655, USA.
  • York K; University of Massachusetts Medical School, Department of Neurology, 55 Lake Avenue North, Worcester, MA, 01655, USA.
  • Radu I; University of Massachusetts Medical School, Department of Neurology, 55 Lake Avenue North, Worcester, MA, 01655, USA.
  • Berrios Morales I; University of Massachusetts Medical School, Department of Neurology, 55 Lake Avenue North, Worcester, MA, 01655, USA.
  • Ionete C; University of Massachusetts Medical School, Department of Neurology, 55 Lake Avenue North, Worcester, MA, 01655, USA.
  • Hemond CC; University of Massachusetts Medical School, Department of Neurology, 55 Lake Avenue North, Worcester, MA, 01655, USA. Electronic address: christopher.hemond@umassmed.edu.
Mult Scler Relat Disord ; 47: 102619, 2021 Jan.
Article em En | MEDLINE | ID: mdl-33189019
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Recidivante-Remitente / Esclerose Múltipla Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Recidivante-Remitente / Esclerose Múltipla Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article